Literature DB >> 16283355

Regulation of Toll-like receptor 4 expression in mouse colon by macrophage migration inhibitory factor.

Tatsuya Ohkawara1, Hiroshi Takeda, Kencho Miyashita, Morie Nishiwaki, Toshinori Nakayama, Masaru Taniguchi, Takashi Yoshiki, Junji Tanaka, Junji Takana, Masahiro Imamura, Toshiro Sugiyama, Masahiro Asaka, Jun Nishihira.   

Abstract

Recent studies have indicated that macrophage migration inhibitory factor (MIF) and Toll-like receptor (TLR) play an important role in the regulation of innate immune responses. In this study, we investigated the effect of MIF on the expression of TLR4, a receptor that recognizes lipopolysaccharide, in colon using MIF-deficient mice. TLR4 mRNA expression in the colon tissues was determined by northern blot analysis. Western blot analysis and immunohistochemistry in the colon tissues were performed to evaluate the expression of TLR4 protein. The expressions of TLR4 mRNA and protein were remarkably down-regulated in colon tissues of MIF-deficient mice compared with wild-type mice and up-regulated by treatment with recombinant MIF. Immunohistochemical study revealed the presence of TLR4-positive staining in mononuclear cells in the lamina propria and intraepithelial mononuclear cells as well as weak staining in epithelial cells and crypts in colon tissues of wild-type mice. In contrast, MIF-deficient mice did not show TLR4-positive staining in the colonic mucosa. In MIF-deficient mice injected with recombinant mouse MIF (rMIF), TLR4-positive staining cells were observed in colon tissues similar to the findings in wild-type mice. Administration of dextran sulfate sodium (DSS) up-regulated the expression of TLR4 in the colons of WT mice but not in those of MIF-deficient mice. Furthermore, pretreatment with rMIF up-regulated the expression of TLR4 in response to DSS in MIF-deficient mice. Our results suggest that MIF affects the expression of TLR4 in mouse colon under both normal and colitic conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283355     DOI: 10.1007/s00418-005-0092-y

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  35 in total

1.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

3.  Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis.

Authors:  T Ohkawara; K Miyashita; J Nishihira; K Mitsuyama; H Takeda; M Kato; N Kondo; Y Yamasaki; M Sata; T Yoshiki; T Sugiyama; M Asaka
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

4.  Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium.

Authors:  Christian Maaser; Lars Eckmann; Günther Paesold; Hyun S Kim; Martin F Kagnoff
Journal:  Gastroenterology       Date:  2002-03       Impact factor: 22.682

5.  Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.

Authors:  Tatsuya Ohkawara; Jun Nishihira; Hiroshi Takeda; Shuhei Hige; Mototsugu Kato; Toshiro Sugiyama; Toshihiko Iwanaga; Hideki Nakamura; Yuka Mizue; Masahiro Asaka
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

6.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

7.  Identification of macrophage migration inhibitory factor (MIF) in human skin and its immmunohistochemical localization.

Authors:  T Shimizu; A Ohkawara; J Nishihira; W Sakamoto
Journal:  FEBS Lett       Date:  1996-03-04       Impact factor: 4.124

Review 8.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

9.  Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis.

Authors:  Thierry Calandra; Céline Froidevaux; Christian Martin; Thierry Roger
Journal:  J Infect Dis       Date:  2003-06-15       Impact factor: 5.226

10.  The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.

Authors:  T Calandra; J Bernhagen; R A Mitchell; R Bucala
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more
  13 in total

1.  Bupropion Ameliorates Acetic Acid-Induced Colitis in Rat: the Involvement of the TLR4/NF-kB Signaling Pathway.

Authors:  Amir Rashidian; Pegah Dejban; Kiana Karami Fard; Alireza Abdollahi; Mohsen Chamanara; Ahmadreza Dehpour; Amin Hasanvand
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

Review 2.  The histochemistry and cell biology vade mecum: a review of 2005-2006.

Authors:  Douglas J Taatjes; Christian Zuber; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2006-11-24       Impact factor: 4.304

Review 3.  Recent progress in histochemistry.

Authors:  Christian Zuber; Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2007-10-31       Impact factor: 4.304

4.  Exploring the interplay of barrier function and leukocyte recruitment in intestinal inflammation by targeting fucosyltransferase VII and trefoil factor 3.

Authors:  P L Beck; E Ihara; S A Hirota; J A MacDonald; D Meng; N N Nanthakumar; D K Podolsky; R J Xavier
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

5.  Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium.

Authors:  Yu-Chen Hou; Chia-Chou Chu; Tsui-Ling Ko; Chiu-Li Yeh; Sung-Ling Yeh
Journal:  Eur J Nutr       Date:  2012-07-31       Impact factor: 5.614

6.  A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

Authors:  Ryan Ungaro; Masayuki Fukata; David Hsu; Yasmin Hernandez; Keith Breglio; Anli Chen; Ruliang Xu; John Sotolongo; Cecillia Espana; Julia Zaias; Greg Elson; Lloyd Mayer; Marie Kosco-Vilbois; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

Review 7.  CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract.

Authors:  Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

Review 8.  Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function.

Authors:  Maria T Abreu
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

9.  Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors.

Authors:  Masayuki Fukata; Yasmin Hernandez; Daisy Conduah; Jason Cohen; Anli Chen; Keith Breglio; Tyralee Goo; David Hsu; Ruliang Xu; Maria T Abreu
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

10.  Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway.

Authors:  Amir Rashidian; Ahad Muhammadnejad; Ahmad-Reza Dehpour; Shahram Ejtemai Mehr; Maziar Mohammad Akhavan; Reza Shirkoohi; Mohsen Chamanara; Seyyedeh-Elaheh Mousavi; Seyed-Mahdi Rezayat
Journal:  Inflammopharmacology       Date:  2016-04-02       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.